Valuation: Philadelphia Pharmaceuticals Company

Market Cap 14.85M 20.95M 18.31M 16.9M 15.57M 29.35M 2.02B 30M 202M 79.43M 988M 78.68M 76.95M 3.4B P/E 2024
13.7x
P/E 2025 11.9x
Enterprise Value 14.78M 20.86M 18.23M 16.82M 15.5M 29.22M 2.01B 29.87M 201M 79.06M 984M 78.32M 76.6M 3.39B EV / Sales 2024
1.32x
EV / Sales 2025 1.3x
Free-Float
7.27%
Yield 2024
4.67%
Yield 2025 -
1 day+5.32%
1 week+18.56%
Current month+18.56%
1 month+18.56%
3 months+32.00%
6 months+25.32%
Current year+23.75%
1 week 1.76
Extreme 1.76
1.98
1 month 1.71
Extreme 1.71
1.98
Current year 1.5
Extreme 1.5
1.98
1 year 1.46
Extreme 1.46
1.98
3 years 1.34
Extreme 1.34
1.98
5 years 1.28
Extreme 1.28
1.98
10 years 1.28
Extreme 1.28
3.42
Manager TitleAgeSince
Chief Executive Officer 44 01/01/2013
Chief Tech/Sci/R&D Officer - -
Director of Finance/CFO 50 01/01/2002
Director TitleAgeSince
Chairman 58 -
Director/Board Member 61 01/09/2016
Director/Board Member 64 01/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
+5.32%+18.56%+33.78%+46.67% 20.95M
-0.90%-0.15%+14.11%+81.10% 48.15B
-0.23%-1.65%+67.15%+112.03% 35.59B
-0.76%-1.44%-4.29%+37.63% 11.9B
-0.88%-0.62%+17.31%+89.97% 11.85B
+0.19%+2.87%+34.92%+139.73% 9.31B
+3.37%-0.10%+51.64%-3.75% 7.02B
-0.75%-0.91%+17.45%+37.70% 6.91B
-2.25%-2.08%+0.45%+209.99% 6.55B
-9.93%+0.35%-31.51%+16.58% 6.13B
Average -0.68%+1.84%+20.10%+76.76% 14.34B
Weighted average by Cap. -0.88%-0.42%+26.79%+86.59%

Financials

2024 2025
Net sales 8.76M 12.36M 10.8M 9.97M 9.19M 17.32M 1.19B 17.7M 119M 46.87M 583M 46.43M 45.41M 2.01B 9.17M 12.94M 11.3M 10.43M 9.62M 18.12M 1.25B 18.53M 125M 49.04M 610M 48.58M 47.52M 2.1B
Net income 822K 1.16M 1.01M 935K 862K 1.62M 112M 1.66M 11.17M 4.39M 54.67M 4.35M 4.26M 188M 1.01M 1.42M 1.24M 1.14M 1.05M 1.99M 137M 2.03M 13.67M 5.38M 66.88M 5.33M 5.21M 230M
Net Debt 334K 471K 411K 380K 350K 659K 45.33M 674K 4.54M 1.78M 22.2M 1.77M 1.73M 76.42M -67.69K -95.49K -83.45K -77.01K -70.98K -134K -9.2M -137K -920K -362K -4.5M -359K -351K -15.5M
Logo Philadelphia Pharmaceuticals Company
Philadelphia Pharmaceuticals Industry Company PSC is a Jordan-based company that is engaged in the development, manufacture and marketing of human pharmaceutical products of different therapeutic categories. The Company, through its production facilities and laboratories located in Amman Industrial state, develops and produces a number of products that includes: Semisolid Dosage Forms, such as creams, ointments, lotions, gels and suppositories, as well as Liquid Dosage Forms, which include syrups, suspensions, solutions, nasal, drops, mouth washes and vaginal douches. Furthermore, the Company undertakes the distribution and marketing of a range of healthcare systems, miscellaneous and pharmaceuticals of different international brand names, including alimentary, gastrointestinal systems and respiratory systems. The Company markets its products to the local markets and exports to more than 10 countries in the Middle East and North Africa region.
Employees
129
Date Price Change Volume
16/07/26 JOD 1.980 +5.32% 6
15/07/26 JOD 1.880 +7.43% 1,721
  1. Stock Market
  2. Stocks
  3. PHIL Stock